(en) Ben Sahra I, Le Marchand-Brustel Y, Tanti JF, Bost F, « Metformin in cancer therapy: a new perspective for an old antidiabetic drug? », Mol Cancer Ther, vol. 9, no 5, , p. 1092-9. (PMID20442309, DOI10.1158/1535-7163.MCT-09-1186, lire en ligne [html])modifier
(en) Varuni Asanka de Silva, Chathurie Suraweera, Suhashini S. Ratnatunga et Madhubashinee Dayabandara, « Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis », BMC Psychiatry, vol. 16, no 1, (ISSN1471-244X, PMID27716110, PMCIDPMC5048618, DOI10.1186/s12888-016-1049-5, lire en ligne, consulté le )
(en) Ita Fitzgerald, Jean O'Connell, Dolores Keating et Caroline Hynes, « Metformin in the management of antipsychotic-induced weight gain in adults with psychosis: development of the first evidence-based guideline using GRADE methodology », Evidence Based Mental Health, vol. 25, no 1, , p. 15–22 (ISSN1362-0347 et 1468-960X, PMID34588212, PMCIDPMC8788031, DOI10.1136/ebmental-2021-300291, lire en ligne, consulté le )
doi.org
dx.doi.org
Marc Foretz et Benoit Viollet, « Les nouvelles promesses de la metformine - Vers une meilleure compréhension de ses mécanismes d’action », médecine/sciences, vol. 30, no 1, , p. 82–92 (ISSN0767-0974 et 1958-5381, DOI10.1051/medsci/20143001018, lire en ligne, consulté le )
Matteo Monami, Riccardo Candido, Basilio Pintaudi et Giovanni Targher, « Effect of metformin on all-cause mortality and major adverse cardiovascular events: An updated meta-analysis of randomized controlled trials », Nutrition, metabolism, and cardiovascular diseases: NMCD, vol. 31, no 3, , p. 699–704 (ISSN1590-3729, PMID33549430, DOI10.1016/j.numecd.2020.11.031, lire en ligne, consulté le )
(en) Varuni Asanka de Silva, Chathurie Suraweera, Suhashini S. Ratnatunga et Madhubashinee Dayabandara, « Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis », BMC Psychiatry, vol. 16, no 1, (ISSN1471-244X, PMID27716110, PMCIDPMC5048618, DOI10.1186/s12888-016-1049-5, lire en ligne, consulté le )
(en) Ita Fitzgerald, Jean O'Connell, Dolores Keating et Caroline Hynes, « Metformin in the management of antipsychotic-induced weight gain in adults with psychosis: development of the first evidence-based guideline using GRADE methodology », Evidence Based Mental Health, vol. 25, no 1, , p. 15–22 (ISSN1362-0347 et 1468-960X, PMID34588212, PMCIDPMC8788031, DOI10.1136/ebmental-2021-300291, lire en ligne, consulté le )
Mitra Niafar, Faizi Hai, Jahan Porhomayon et Nader Djalal Nader, « The role of metformin on vitamin B12 deficiency: a meta-analysis review », Internal and Emergency Medicine, vol. 10, no 1, , p. 93–102 (ISSN1970-9366, PMID25502588, DOI10.1007/s11739-014-1157-5, lire en ligne, consulté le )
(en) Shao C, Ahmad N, Hodges K, Kuang S, Ratliff T, Liu X, « Inhibition of Polo-like Kinase 1 (Plk1) Enhances the Antineoplastic Activity of Metformin in Prostate Cancer », J Biol Chem, vol. 290, no 4, , p. 2024-33. (PMID25505174, DOI10.1074/jbc.M114.596817)modifier
(en) Ben Sahra I, Le Marchand-Brustel Y, Tanti JF, Bost F, « Metformin in cancer therapy: a new perspective for an old antidiabetic drug? », Mol Cancer Ther, vol. 9, no 5, , p. 1092-9. (PMID20442309, DOI10.1158/1535-7163.MCT-09-1186, lire en ligne [html])modifier
(en) Wang J, Gallagher D, DeVito LM, Cancino GI, Tsui D, He L, Keller GM, Frankland PW, Kaplan DR, Miller FD, « Metformin activates an atypical PKC-CBP pathway to promote neurogenesis and enhance spatial memory formation », Cell Stem Cell, vol. 11, no 1, , p. 23-35. (PMID22770240, DOI10.1016/j.stem.2012.03.016)modifier
Ibrahim Mohammed, Morley D. Hollenberg, Hong Ding et Chris R. Triggle, « A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan », Frontiers in Endocrinology, vol. 12, , p. 718942 (ISSN1664-2392, PMID34421827, PMCID8374068, DOI10.3389/fendo.2021.718942, lire en ligne, consulté le )
Austin J. Parish et William R. Swindell, « Metformin has heterogeneous effects on model organism lifespans and is beneficial when started at an early age in Caenorhabditis elegans: A systematic review and meta-analysis », Aging Cell, vol. 21, no 12, , e13733 (ISSN1474-9726, PMID36281624, PMCIDPMC9741508, DOI10.1111/acel.13733, lire en ligne, consulté le )
issn.org
portal.issn.org
Marc Foretz et Benoit Viollet, « Les nouvelles promesses de la metformine - Vers une meilleure compréhension de ses mécanismes d’action », médecine/sciences, vol. 30, no 1, , p. 82–92 (ISSN0767-0974 et 1958-5381, DOI10.1051/medsci/20143001018, lire en ligne, consulté le )
Matteo Monami, Riccardo Candido, Basilio Pintaudi et Giovanni Targher, « Effect of metformin on all-cause mortality and major adverse cardiovascular events: An updated meta-analysis of randomized controlled trials », Nutrition, metabolism, and cardiovascular diseases: NMCD, vol. 31, no 3, , p. 699–704 (ISSN1590-3729, PMID33549430, DOI10.1016/j.numecd.2020.11.031, lire en ligne, consulté le )
(en) Varuni Asanka de Silva, Chathurie Suraweera, Suhashini S. Ratnatunga et Madhubashinee Dayabandara, « Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis », BMC Psychiatry, vol. 16, no 1, (ISSN1471-244X, PMID27716110, PMCIDPMC5048618, DOI10.1186/s12888-016-1049-5, lire en ligne, consulté le )
(en) Ita Fitzgerald, Jean O'Connell, Dolores Keating et Caroline Hynes, « Metformin in the management of antipsychotic-induced weight gain in adults with psychosis: development of the first evidence-based guideline using GRADE methodology », Evidence Based Mental Health, vol. 25, no 1, , p. 15–22 (ISSN1362-0347 et 1468-960X, PMID34588212, PMCIDPMC8788031, DOI10.1136/ebmental-2021-300291, lire en ligne, consulté le )
Mitra Niafar, Faizi Hai, Jahan Porhomayon et Nader Djalal Nader, « The role of metformin on vitamin B12 deficiency: a meta-analysis review », Internal and Emergency Medicine, vol. 10, no 1, , p. 93–102 (ISSN1970-9366, PMID25502588, DOI10.1007/s11739-014-1157-5, lire en ligne, consulté le )
Ibrahim Mohammed, Morley D. Hollenberg, Hong Ding et Chris R. Triggle, « A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan », Frontiers in Endocrinology, vol. 12, , p. 718942 (ISSN1664-2392, PMID34421827, PMCID8374068, DOI10.3389/fendo.2021.718942, lire en ligne, consulté le )
Austin J. Parish et William R. Swindell, « Metformin has heterogeneous effects on model organism lifespans and is beneficial when started at an early age in Caenorhabditis elegans: A systematic review and meta-analysis », Aging Cell, vol. 21, no 12, , e13733 (ISSN1474-9726, PMID36281624, PMCIDPMC9741508, DOI10.1111/acel.13733, lire en ligne, consulté le )
Marc Foretz et Benoit Viollet, « Les nouvelles promesses de la metformine - Vers une meilleure compréhension de ses mécanismes d’action », médecine/sciences, vol. 30, no 1, , p. 82–92 (ISSN0767-0974 et 1958-5381, DOI10.1051/medsci/20143001018, lire en ligne, consulté le )
Matteo Monami, Riccardo Candido, Basilio Pintaudi et Giovanni Targher, « Effect of metformin on all-cause mortality and major adverse cardiovascular events: An updated meta-analysis of randomized controlled trials », Nutrition, metabolism, and cardiovascular diseases: NMCD, vol. 31, no 3, , p. 699–704 (ISSN1590-3729, PMID33549430, DOI10.1016/j.numecd.2020.11.031, lire en ligne, consulté le )
(en) Varuni Asanka de Silva, Chathurie Suraweera, Suhashini S. Ratnatunga et Madhubashinee Dayabandara, « Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis », BMC Psychiatry, vol. 16, no 1, (ISSN1471-244X, PMID27716110, PMCIDPMC5048618, DOI10.1186/s12888-016-1049-5, lire en ligne, consulté le )
(en) Ita Fitzgerald, Jean O'Connell, Dolores Keating et Caroline Hynes, « Metformin in the management of antipsychotic-induced weight gain in adults with psychosis: development of the first evidence-based guideline using GRADE methodology », Evidence Based Mental Health, vol. 25, no 1, , p. 15–22 (ISSN1362-0347 et 1468-960X, PMID34588212, PMCIDPMC8788031, DOI10.1136/ebmental-2021-300291, lire en ligne, consulté le )
Mitra Niafar, Faizi Hai, Jahan Porhomayon et Nader Djalal Nader, « The role of metformin on vitamin B12 deficiency: a meta-analysis review », Internal and Emergency Medicine, vol. 10, no 1, , p. 93–102 (ISSN1970-9366, PMID25502588, DOI10.1007/s11739-014-1157-5, lire en ligne, consulté le )
(en) Shao C, Ahmad N, Hodges K, Kuang S, Ratliff T, Liu X, « Inhibition of Polo-like Kinase 1 (Plk1) Enhances the Antineoplastic Activity of Metformin in Prostate Cancer », J Biol Chem, vol. 290, no 4, , p. 2024-33. (PMID25505174, DOI10.1074/jbc.M114.596817)modifier
(en) Ben Sahra I, Le Marchand-Brustel Y, Tanti JF, Bost F, « Metformin in cancer therapy: a new perspective for an old antidiabetic drug? », Mol Cancer Ther, vol. 9, no 5, , p. 1092-9. (PMID20442309, DOI10.1158/1535-7163.MCT-09-1186, lire en ligne [html])modifier
(en) Wang J, Gallagher D, DeVito LM, Cancino GI, Tsui D, He L, Keller GM, Frankland PW, Kaplan DR, Miller FD, « Metformin activates an atypical PKC-CBP pathway to promote neurogenesis and enhance spatial memory formation », Cell Stem Cell, vol. 11, no 1, , p. 23-35. (PMID22770240, DOI10.1016/j.stem.2012.03.016)modifier
Ibrahim Mohammed, Morley D. Hollenberg, Hong Ding et Chris R. Triggle, « A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan », Frontiers in Endocrinology, vol. 12, , p. 718942 (ISSN1664-2392, PMID34421827, PMCID8374068, DOI10.3389/fendo.2021.718942, lire en ligne, consulté le )
Austin J. Parish et William R. Swindell, « Metformin has heterogeneous effects on model organism lifespans and is beneficial when started at an early age in Caenorhabditis elegans: A systematic review and meta-analysis », Aging Cell, vol. 21, no 12, , e13733 (ISSN1474-9726, PMID36281624, PMCIDPMC9741508, DOI10.1111/acel.13733, lire en ligne, consulté le )
pubmed.ncbi.nlm.nih.gov
Matteo Monami, Riccardo Candido, Basilio Pintaudi et Giovanni Targher, « Effect of metformin on all-cause mortality and major adverse cardiovascular events: An updated meta-analysis of randomized controlled trials », Nutrition, metabolism, and cardiovascular diseases: NMCD, vol. 31, no 3, , p. 699–704 (ISSN1590-3729, PMID33549430, DOI10.1016/j.numecd.2020.11.031, lire en ligne, consulté le )
Mitra Niafar, Faizi Hai, Jahan Porhomayon et Nader Djalal Nader, « The role of metformin on vitamin B12 deficiency: a meta-analysis review », Internal and Emergency Medicine, vol. 10, no 1, , p. 93–102 (ISSN1970-9366, PMID25502588, DOI10.1007/s11739-014-1157-5, lire en ligne, consulté le )
Austin J. Parish et William R. Swindell, « Metformin has heterogeneous effects on model organism lifespans and is beneficial when started at an early age in Caenorhabditis elegans: A systematic review and meta-analysis », Aging Cell, vol. 21, no 12, , e13733 (ISSN1474-9726, PMID36281624, PMCIDPMC9741508, DOI10.1111/acel.13733, lire en ligne, consulté le )
(en) World Health Organization, Management of physical health conditions in adults with severe mental disorders: WHO guidelines, World Health Organization, (ISBN978-92-4-155038-3, lire en ligne)
(en) Shao C, Ahmad N, Hodges K, Kuang S, Ratliff T, Liu X, « Inhibition of Polo-like Kinase 1 (Plk1) Enhances the Antineoplastic Activity of Metformin in Prostate Cancer », J Biol Chem, vol. 290, no 4, , p. 2024-33. (PMID25505174, DOI10.1074/jbc.M114.596817)modifier
(en) Ben Sahra I, Le Marchand-Brustel Y, Tanti JF, Bost F, « Metformin in cancer therapy: a new perspective for an old antidiabetic drug? », Mol Cancer Ther, vol. 9, no 5, , p. 1092-9. (PMID20442309, DOI10.1158/1535-7163.MCT-09-1186, lire en ligne [html])modifier
(en) Wang J, Gallagher D, DeVito LM, Cancino GI, Tsui D, He L, Keller GM, Frankland PW, Kaplan DR, Miller FD, « Metformin activates an atypical PKC-CBP pathway to promote neurogenesis and enhance spatial memory formation », Cell Stem Cell, vol. 11, no 1, , p. 23-35. (PMID22770240, DOI10.1016/j.stem.2012.03.016)modifier